United States: The Defend Trade Secrets Act: Significant Recent Changes To Intellectual Property Law May Provide New Avenues For Protecting Potentially Unpatentable Critical Discoveries

Last Updated: July 15 2016
Article by Dorothy R. Auth and David Cole

Most Read Contributor in United States, August 2018

I. Introduction

On May 11, 2016, President Obama signed into law the Defend Trade Secrets Act ("DTSA"), marking one of largest changes to intellectual property law since the America Invents Act of 2011. This legislation will allow companies to more rigorously protect their trade secrets which are defined as any information that is not generally known to the public, whose holder has made reasonable efforts to maintain its secrecy, where an independent economic value is derived from that secrecy.

Unlike patents, trade secrets are not disclosed to the public, making them a potentially attractive alternative to patents for some IP rights holders. Moreover, trade secrets also lack a patent's statutorily-limited exclusivity period; however, any third party who lawfully learns or independently develops a trade secret may practice it without liability to the owner. The protection of trade secrets and the ability to prevent their dissemination can, therefore, be of paramount importance to any company relying on trade secrets to protect their IP. Although theft of trade secrets has been a federal crime since the Economic Espionage Act of 1996 ("EEA"), the DTSA amends the EEA to create Federal civil liability for trade secret misappropriation.

Bolstering trade secret law comes at a critical time for various industries, such as software developers and biotech and pharmaceutical companies, who are increasingly discovering that their previously patentable innovations are no longer patent-eligible. In Alice Corp. v. CLS Bank International, 134 S. Ct. 2347, 2357-60 (2014), the Supreme Court held that inventions directed to laws of nature, natural phenomena, and abstract ideas are not patent-eligible unless the patent claims add an "inventive concept" to the claims. Following this holding, courts have begun to invalidate vast numbers of software and business-method patents.

Pharmaceutical and medical device companies also have found their patents invalidated as no longer patent-eligible under Alice. For example, in Mayo Collaborative Services v. Prometheus Laboratories, 132 S. Ct. 1289, 1294-99 (2012), the Supreme Court found that a medical discovery related to the relationship between metabolites in blood and a response to a certain therapeutic drug was not patentable because it represented a "principle of nature." Similarly, in Association for Molecular Pathology v. Myriad Genetics, 133 S. Ct. 2107, 2116-20 (2013), the Supreme Court found that the discovery of the precise location and genetic sequence of certain DNA strands that could be used to screen for cancer was not patentable because the claims did not do more than attempt to claim the naturally-occurring DNA sequence. Both decisions voided the patent protection for significant medical advancements, and could serve to stifle medical innovation going forward. Significantly, in Ariosa v. Sequenom, 788 F.3d 1371, 1375-80 (Fed. Cir. 2015), the Federal Circuit was compelled under this caselaw to find that a method of detecting and extracting cell-free fetal DNA constituted patent-ineligible subject matter, despite the Federal Circuit's agreement that the "previously-unknown," "valuable," "groundbreaking," and "breakthrough" discovery was superior to the riskier methods previously practiced by practitioners. In denying rehearing of the case, the Federal Circuit Judges wrote concurrences and dissents sharply criticizing current patent eligibility law as overly restrictive and potentially stifling innovation. However, on June 27, 2016, the Supreme Court denied certiorari, apparently ending the hopes for any immediate reform to patent eligibility law. Ariosa v. Sequenom, No. 15-1182 (S. Ct. June 27, 2016).

In this current environment, software and pharmaceutical companies may find that the innovations and discoveries critical for their success may not be protectable under U.S. patent law. As such, these companies are not incentivized to disclose their inventions to the public, but rather may turn to trade secret protection as an alternative method to protect innovation despite the current state of patent eligibility law.

II. Provisions of the DTSA

Employers considering protecting their intellectual property through trade secrets under the DTSA should, therefore, be aware of the possibilities and requirements of the new law. Prior to the DTSA, were no federal laws providing for civil enforcement of trade secrets, and, therefore, all trade secret misappropriation claims was governed by and adjudicated under state law. All but two states have enacted legislation based on the Uniform Trade Secrets Act ("UTSA"), which was used as the model for the DTSA. The DTSA does not preempt any state law, however, and applies only to misappropriation of trade secrets that are "related to a product or service used in, or intended for use in, interstate or foreign commerce." See 18 U.S.C. § 1836(b). Several additional provisions of the DTSA are noteworthy because they represent a significant change from the UTSA and require owners to take certain steps.

1. Civil Seizure

Under the DTSA, a plaintiff alleging misappropriation of their trade secrets may seek an injunction to seize property necessary to prevent dissemination of the trade secret. Any such seizure may be done ex parte, meaning the defendant may have its property seized pursuant to a federal judge's orders without prior notice to defendants by law enforcement officials. Although this provision has been heavily discussed and has given rise to concerns that malicious competitors could groundlessly seize their competitors' property without notice, the DTSA in fact provides numerous safeguards preventing such conduct. For example, plaintiffs seeking seizure must show that (i) other forms of equitable relief would be inadequate, (ii) immediate and irreparably injury would occur if not for seizure, (iii) the harm of denying the application for seizure outweighs the harm to the legitimate interests of the defendant and substantially outweighs harm to any third parties, (iv) the plaintiff is likely to succeed on the merits, (v) the defendant is actually in possession of the trade secret, (vi) the request for seizure is narrowly tailored to the circumstances, (vii) the material to be seized would be destroyed, moved, or otherwise made inaccessible if the applicant provided notice, and (viii) the applicant has not publicized the requested seizure. See 18 U.S.C. § 1836(b)(2)(A)(ii). The ex parte seizure provision is intended to prevent a potentially catastrophic misappropriation of a company's trade secrets while also protecting potential targets of seizure from baseless allegations.

2. Protection for Whistleblowers

The DTSA contains a whistleblower clause that provides immunity for employees who disclose trade secrets to government officials for the sole purpose of reporting illegal activities. Employers are required to provide notice of this immunity to employees in any contract governing the use of trade secrets or other confidential information. 18 U.S.C. § 1833(b)(3)(A). Failure to comply with this requirement can result in the employer being unable to recover exemplary damages or attorney's fees in trade secret misappropriation litigation with an employee not provided with the required notice. As such, employers should update their standard employment agreements to ensure compliance with this new provision of DTSA.

III. Conclusion

While the full impact of the provisions of the DTSA still is unfolding, the DTSA already is being utilized by trade secret holders to protect their intellectual property in federal courts. For example, in Henry Schein Inc. v. Cook, No. 16-cv-03166-JST, 2016 U.S. Dist. LEXIS 76038 (N.D. Cal. June 10, 2016), the Northern District of California granted a temporary injunction preventing a former employee of the plaintiff and her new company from using information allegedly stolen from her previous employer. There, the ex-employee allegedly downloaded numerous files, including important customer data, from the plaintiff and brought them to her new employer, a direct competitor of the plaintiff. The court, exercising federal jurisdiction under the DTSA, granted the plaintiff a temporary restraining order, preventing the ex-employee from discussing, disseminating, or disclosing any of the misappropriated customer data while the action is pending.

The federal civil cause of action for trade secret misappropriation granted under the DTSA has fundamentally changed the way employers may protect their intellectual property, and it remains to be seen whether plaintiffs, and which sorts of plaintiffs, will choose federal courts to file and adjudicate their trade secret disputes. Technology companies may choose to protect certain aspects of their innovations increasingly through trade secret law rather than risk a public disclosure of their invention being held to be patent-ineligible. The availability of federal trade secret action for misappropriation is a potentially important weapon for such companies. In addition, because the DTSA does not preempt state law, plaintiffs may pursue DTSA claims in conjunction with UTSA or various other state tort claims.

The impact and frequency of use of the DTSA has not yet been determined, but the current caselaw landscape in the patent area suggests the DTSA has arrived just in time to provide much needed protections for many technology companies. Moreover, the DTSA also may lead to greater protections for employers facing potentially critical trade secret theft.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
Seyfarth Shaw LLP
McLane Middleton, Professional Association
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Seyfarth Shaw LLP
McLane Middleton, Professional Association
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions